These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6971938)

  • 1. Immunobiology of D-penicillamine.
    Dawkins RL; Zilko PJ; Carrano J; Garlepp MJ; McDonald BL
    J Rheumatol Suppl; 1981; 7():56-61. PubMed ID: 6971938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [D-penicillamine: mechanism of cellular action and induced autoimmune diseases].
    Meyer O
    Rev Rhum Mal Osteoartic; 1986 Jan; 53(1):15-20. PubMed ID: 2939541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [D-penicillamine-induced myasthenia gravis].
    Frey RA; Keller F; Michel BA
    Schweiz Med Wochenschr; 1994 May; 124(20):852-6. PubMed ID: 8209208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylcholine receptor antibody characteristics in myasthenia gravis. II. Patients with penicillamine-induced myasthenia or idiopathic myasthenia of recent onset.
    Vincent A; Newsom-Davis J
    Clin Exp Immunol; 1982 Aug; 49(2):266-72. PubMed ID: 7127905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoregulation of autoimmune diseases.
    van Eden W
    Hum Immunol; 2006 Jun; 67(6):446-53. PubMed ID: 16728268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell responses to D-penicillamine in drug-induced myasthenia gravis: recognition of modified DR1:peptide complexes.
    Hill M; Moss P; Wordsworth P; Newsom-Davis J; Willcox N
    J Neuroimmunol; 1999 Jun; 97(1-2):146-53. PubMed ID: 10408968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myasthenia gravis and D-penicillamine.
    Dawkins RL; Garlepp MJ; McDonald BL; Williamson J; Zilko PJ; Carrano J
    J Rheumatol Suppl; 1981; 7():169-74. PubMed ID: 7014873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Penicillamine-induced myasthenia gravis].
    Dtsch Med Wochenschr; 1983 Sep; 108(39):1499. PubMed ID: 6578008
    [No Abstract]   [Full Text] [Related]  

  • 9. [D-penicillamine induced myasthenic syndromes in rheumatoid arthritis. Two cases (author's transl)].
    Rodat O; Hamelin JP; Rossard A; Cottin S; Cler JM; Rodat G; Lemouroux P
    Nouv Presse Med; 1981 May; 10(20):1645-8. PubMed ID: 7255126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA class II transgenic mice mimic human inflammatory diseases.
    Mangalam AK; Rajagopalan G; Taneja V; David CS
    Adv Immunol; 2008; 97():65-147. PubMed ID: 18501769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [D-penicillamine-induced pemphigus, polymyositis and myasthenia].
    Jan V; Callens A; Machet L; Machet MC; Lorette G; Vaillant L
    Ann Dermatol Venereol; 1999 Feb; 126(2):153-6. PubMed ID: 10352832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new mouse model of autoimmune ocular myasthenia gravis.
    Yang H; Wu B; Tüzün E; Saini SS; Li J; Allman W; Higgs S; Xiao TL; Christadoss P
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5101-11. PubMed ID: 17962462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of T cell subpopulations and recombinant interleukin (IL)-2 on peripheral B cell function in patients with myasthenia gravis.
    Zhang J; Zhou WB; Wang HL; Guo SS
    Hum Antibodies; 1997; 8(2):90-4. PubMed ID: 9289393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TCR gene usage in experimental autoimmune myasthenia gravis pathogenesis. Usage of multiple TCRBV genes in the H-2b strains.
    Wu B; Shenoy M; Goluszko E; Kaul R; Christadoss P
    J Immunol; 1995 Apr; 154(7):3603-10. PubMed ID: 7897239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards antigen-specific apheresis of pathogenic autoantibodies as a further step in the treatment of myasthenia gravis by plasmapheresis.
    Zisimopoulou P; Lagoumintzis G; Kostelidou K; Bitzopoulou K; Kordas G; Trakas N; Poulas K; Tzartos SJ
    J Neuroimmunol; 2008 Sep; 201-202():95-103. PubMed ID: 18667243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-Penicillamine-associated myasthenia gravis: immunological and electrophysiological studies.
    Fawcett PR; McLachlan SM; Nicholson LV; Argov Z; Mastaglia FL
    Muscle Nerve; 1982 Apr; 5(4):328-34. PubMed ID: 7099199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Animal models of myasthenia gravis.
    Christadoss P; Poussin M; Deng C
    Clin Immunol; 2000 Feb; 94(2):75-87. PubMed ID: 10637092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of experimental myasthenia gravis by a B-cell epitope-free recombinant acetylcholine receptor.
    Yi HJ; Chae CS; So JS; Tzartos SJ; Souroujon MC; Fuchs S; Im SH
    Mol Immunol; 2008 Nov; 46(1):192-201. PubMed ID: 18799218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Follow-up and immunologic findings in drug-induced myasthenia].
    Brüggemann W; Herath H; Ferbert A
    Med Klin (Munich); 1996 May; 91(5):268-71. PubMed ID: 8709903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infections and autoimmune diseases.
    Bach JF
    J Autoimmun; 2005; 25 Suppl():74-80. PubMed ID: 16278064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.